Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Gastroenterology
Dr. Arun Sanyal, MD
|
|
Give Review
Doctor Arun Sanyal, MD is an expert in the field of Gastroenterology. He studied medicine at Maulana Azad Medical College. Arun Sanyal is also published. He has 50 publications published. The lastest publication: "Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.' He is registered with Medicare and accepts Medicare payments.
Publications
- Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-α and -δ, Induces Resolution of Nonalcoholic SteatoHepatitis Without Fibrosis Worsening.
- Management of NAFLD: a stage-based approach.
- A model of acute kidney injury in mice with Cirrhosis and infection.
- Diabetes and prediabetes in patients with Hepatitis B residing in North America.
- Use of the Methacetin Breath Test to Classify the Risk of Cirrhotic Complications and Mortality in Patients Evaluated/Listed for Liver Transplantation.
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatoHepatitis: Findings and recommendations from an American Association for the Stud...
- Nonalcoholic SteatoHepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
- Evolution of the serum atherogenic risk in liver transplant recipients; role of lipoproteins, metabolic and inflammatory markers.
- ACTIVATION OF THE GP130-STAT3 AXIS AND ITS POTENTIAL IMPLICATIONS IN NONALCOHOLIC FATTY LIVER Disease.
- Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy.
- NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.
- Nonendoscopic Management Strategies for Acute EsophagoGastric Variceal Bleeding.
- Transjugular Intrahepatic PortoSystemic Shunt.
- Myths and Mysteries About Staging Hepatic Fibrosis by Fibroscan.
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Associate With Atherogenic Lipoprotein Profile.
- Cognitive Reserve Is a Determinant of Health-related Quality of Life in Patients With Cirrhosis, Independent of Covert Hepatic Encephalopathy and Model for End-Stage L...
- Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.
- Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization.
- Effects of Obstructive Sleep Apnea on Sleep Quality, Cognition, and Driving Performance in Patients with Cirrhosis.
- Validation of Non-invasive Methods for Detecting Hepatic Steatosis in Patients with HIV Infection.
- Colonic inflammation and secondary bile acids in alcoholic Cirrhosis.
- Circulating microRNA signature in non-alcoholic fatty liver Disease: from serum non-coding RNAs to liver histology and Disease pathogenesis.
- Validation of EncephalApp, Smartphone-based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
- Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis.
- METABOLIC PROFILING REVEALS THAT PNPLA3 INDUCES WIDESPREAD EFFECTS ON METABOLISM BEYOND TRIACYLGLYCEROL REMODELING IN HUH-7 HEPATOMA CELLS.
- Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with Cirrhosis.
- Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liv...
- Readiness for Behavior Change in Non-Alcoholic Fatty Liver Disease: Implications for Multidisciplinary Care Models.
- Diagnosis of Covert Hepatic Encephalopathy Without Specialized Tests.
- Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
- The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cirrhosis and its Complications.
- Post Paracentesis Circulatory Derangements are related to Monocyte activation.
- Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival.
- Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver Disease.
- Differential Impact of Hyponatremia and Hepatic Encephalopathy on Health-Related Quality of Life and Brain Metabolite Abnormalities in Cirrhosis.
- The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor-induced hepatic lipotoxicity in mice.
- 5-cholesten-3?,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic Fatty liver Disease mouse model.
- The stroop smartphone APP is a short and valid method toscreen for minimal hepatic encephalopathy.
- The molecular pathogenesis of cholestasis in sepsis.
- Scavenger receptor a restrains T-cell activation and protects against concanavalin A-induced hepatic injury.
- Asymmetric Di-methyl Arginine is Strongly Associated with Cognitive Dysfunction and Brain MR Spectroscopic Abnormalities in Cirrhosis.
- Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
- The effect of fatigue on driving skills in patients with hepatic encephalopathy.
- Nonalcoholic steatoHepatitis is associated with altered hepatic MicroRNA expression.
- Long term changes in liver histology following treatment of chronic Hepatitis C virus.
- Release of GLP-1 and PYY in Response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S.
- Drug-induced fatty liver Disease: An overview of pathogenesis and management.
- Modulation of the metabiome by rifaximin in patients with Cirrhosis and minimal hepatic encephalopathy.
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver Disease.
Schools
Maulana Azad Medical College Delhi University
Tex Tech University Health Scis Center
Med College Va
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Biliary Atresia
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Education
-
Virginia Commonwealth University Health System -
Maulana Azad Medical College
Drug Facts
| NPI NUMBER | 1629168273 | |
| NPPES Provider LastName | SANYAL | |
| NPPES Provider FirstName | ARUN | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 41.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629168273 |
| Last Name Of The Provider | SANYAL |
| First Name Of The Provider | ARUN |
| View All |
Similar Doctors
|
Dr. Puneet Kumar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Horace J. Jackson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William T. Brand Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Souheil G. Abou-Assi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George B. Smallfield III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael T. Farrell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Iliana S. Bouneva, MD |
|
Dr. Rufus C. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald M. Switz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doumit S. Bouhaidar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andy J. Thanjan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eddy Pizzani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Pandak Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nevin Yilmaz, MD |
|
Mankanchan S. Majhail, FNP
This Doctor is OpenDoctor Recommended.
|